Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1996
Business Overview: The Company manufactures and distributes natural health and nutritional products through a direct sales marketing program utilizing an independent sales force of Managers and Distributors. Operations are conducted domestically and internationally.
Key Financial Metrics
| Metric (in thousands) | Q1 1996 | Q1 1995 |
|---|---|---|
| Sales Revenue | $60,113 | $47,062 |
| Operating Income | $5,080 | $2,987 |
| Net Income | $3,276 | $2,014 |
| Diluted EPS | $0.17 | $0.11 |
| Operating Cash Flow | $11,125 | $5,226 |
| Cash and Equivalents (End of Period) | $22,877 | $13,832 |
| Short-term Debt | $2,768 | $2,042 |
| Total Assets | $76,802 | $65,247 |
Margins (Q1 1996):
- Gross Margin (Sales less COGS): 82.7%
- Operating Margin: 8.5%
- Net Profit Margin: 5.5%
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 27.7% to $60.1 million, driven by a 32% increase in international sales ($19.8 million) and expansion of the independent sales force (Managers increased to 14,268; Distributors to 427,777).
- Profitability: Net income rose 62.7% to $3.3 million. Operating income increased 70.1% to $5.1 million.
- Expense Trends:
- Cost of Goods Sold (COGS): Decreased as a percentage of sales from 19.6% to 17.3% due to volume efficiencies.
- Volume Incentives: Increased 28.0% to $27.9 million (46.4% of sales), directly correlating with sales growth.
- SG&A Expenses: Increased 28.4% to $16.8 million, including startup costs for new operations in Guatemala, El Salvador, Panama, and Peru.
- Liquidity: Cash and cash equivalents increased by $8.7 million, primarily due to strong operating cash flows ($11.1 million).
Outlook, Risks, and Management Commentary
- Guidance: Management expects COGS and volume incentives to decrease slightly as a percentage of sales for the remainder of 1996, aided by sales growth in Japan and Brazil. SG&A is also expected to decrease as a percentage of sales.
- Capital Allocation:
- Capital expenditures were $2.8 million for manufacturing and administrative improvements.
- Dividends of 3 1/3 cents per share were declared (31st consecutive quarterly dividend).
- A stock buyback program remains active with approximately 153,000 shares remaining to be purchased.
- Future Projects: The Company is establishing a new international subsidiary requiring approximately $1 million in initial capitalization over the next 12-18 months. Domestic facility expansion is being evaluated.
- Risks:
- Foreign Exchange: International operations expose the Company to currency fluctuations.
- Legal: The Company is a defendant in various incidental lawsuits; management believes these will not have a material effect on financial position.
Investor Verification Checklist
- Verify the sustainability of the 28% sales growth rate and the continued expansion of the independent sales force.
- Monitor the impact of new international operations (Guatemala, El Salvador, Panama, Peru) on SG&A expenses and profitability.
- Assess the Company's ability to maintain gross margins as volume incentives remain a significant portion of revenue (46.4%).
- Review the progress and capital requirements of the new international subsidiary and potential domestic facility expansions.
- Confirm the status of the stock buyback program and future dividend declarations.